Newsfeeds - Spark Newswire

1 minute read

HC Wainwright & Co. Downgrades BioDelivery Sciences Intl to Neutral, Lowers Price Target to $4.5

Today, 1:10 PM

HC Wainwright & Co. analyst Oren Livnat downgrades BioDelivery Sciences Intl (NASDAQ:BDSI) from Buy to Neutral and lowers the price target from $6 to $4.5.

BDSI

25 minute read

Earnings Scheduled For November 3, 2021

By Benzinga Insights

Today, 1:10 PM

Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.

AAWW

4 minute read

50 Biggest Movers From Yesterday

By Lisa Levin

Today, 1:10 PM

Gainers

ACY

3 minute read

32 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 1:10 PM

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 53.1% to $8.71 following an announcement from management that the company entered into a revenue share agreement with Google LLC to develop its enterprise tech platform and software products.

ADBE

6 minute read

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs

By Shanthi Rexaline

Today, 1:10 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20)

ABEO

1 minute read

Legal
News

BioDelivery Sciences International Says Filed Motion For Order To Show Cause Why Defendants Should Not Be Held In Contempt For Violating Court Order Of June, 28, 2021

By Benzinga Newsdesk

Today, 1:10 PM

-SEC Filing

BDSI

1 minute read

FDA
News

BioDelivery Sciences To Exhibit 3 Scientific Posters Comparing BELBUCA To Oxycodone At PAINWeek 2021 Conference

By Benzinga Newsdesk

Today, 1:10 PM

Risk Stratification of Respiratory Depression With Buprenorphine Buccal Film Versus Oxycodone: Outcomes From a Phase 1 Placebo-Controlled Trial Authors: Lynn Webster, MD; Jacqueline Cater, PhD; Thomas Smith,

BDSI